Again acquires Geno to combine AI-driven discovery with industrial biomanufacturing

Again, a technology company, has acquired Genomatica, an industrial biotechnology company, to combine their AI-driven discovery with industrial biomanufacturing. The financial terms of the transaction were not disclosed. Again specializes in multi-feedstock production pathways for manufacturing industrial products from various raw materials, while Genomatica has developed an AI and computational biotechnology platform, patent portfolio, and data from experimental research, structural analysis, scale-up processes, and development outcomes.

The acquisition allows Again to integrate Genomatica's assets into its computational platform, enhancing its modeling capabilities and reducing the development cycle for new production pathways and products. Together, the companies will have capabilities spanning pathway discovery, process development, and industrial-scale production.

Brief written by urgent.news from Tech.eu's own syndicated text. Machine-written — it may contain errors, so check the original before relying on it.